Entecavir demonstrates consistent responses among baseline subgroups in the treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B

Brown R., Lok A., Gish R., Schiff E., Shouval D., Senturk H., ...More

Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, United States Of America, 14 - 19 May 2005, vol.128 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 128
  • City: Illinois
  • Country: United States Of America
  • Bezmialem Vakıf University Affiliated: Yes